SkyePharma wins Japanese approval for inhaled Flutiform; SafeShot gathers $9M for injectables biz;

> The Japanese Ministry of Health approved SkyePharma's inhaled asthma treatment Flutiform, giving the company "several million" in milestone payments from its Japanese partner, Kyorin Pharmaceutical. Item

> SafeShot Technologies secured $9 million in financing--$6 million now on top of $3 million from 2012--which it will use to bolster its sterile injectable business. Release

> Researchers at the University of Twente in the Netherlands have developed multifunctional nanocontainers for imaging, targeting and drug release. Story

> Oramed ($ORMP) will participate in Barclays' Israel Biotech Corporate Day in Zurich, Switzerland, this month. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.